Antiserum from mice vaccinated with modified vaccinia Ankara virus expressing African horse sickness virus (AHSV) VP2 provides protection when it is administered 48 h before, or 48 h after challenge

Previous studies show that a recombinant modified vaccinia Ankara (MVA) virus expressing VP2 of AHSV serotype 4 (MVA-VP2) induced virus neutralising antibodies in horses and protected interferon alpha receptor gene knock-out mice (IFNAR −/−) against challenge. Follow up experiments indicated that pa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antiviral Res
Main Authors: Calvo-Pinilla, Eva, de la Poza, Francisco, Gubbins, Simon, Mertens, Peter Paul Clement, Ortego, Javier, Castillo-Olivares, Javier
Formato: Artigo
Idioma:Inglês
Publicado em: The Authors. Published by Elsevier B.V. 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7125940/
https://ncbi.nlm.nih.gov/pubmed/25643968
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2015.01.009
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados